Logo
x

Search

Subscribe Now

HIV

Gilead Reports the EMA’s MAA and EU-M4all Acceptance of Lenacapavir for Pre-Exposure Prophylaxis (PreP) to Prevent HIV in Individuals at Risk

Gilead Reports the EMA’s MAA and EU-M4all Acceptance of Lenacapavir for Pre-Exposure Prophylaxis (PreP) to Prevent HIV in Individu...

  • February 25, 2025
Gilead Reports US FDA’s NDA Acceptance of Lenacapavir for Pre-Exposure Prophylaxis (PreP) to Prevent HIV in Individuals at Risk

Gilead Reports US FDA’s NDA Acceptance of Lenacapavir for Pre-Exposure Prophylaxis (PreP) to Prevent HIV in Individuals at Risk

  • February 19, 2025
ViiV Healthcare Reports the EC’s Approval of Vocabria + Rekambys to Treat HIV

ViiV Healthcare Reports the EC’s Approval of Vocabria + Rekambys to Treat HIV

  • January 31, 2025
MedMira’s Multiplo(R) Rapid (TP/HIV) Test Secures the Health Canada’s Approval for Syphilis and HIV

MedMira’s Multiplo(R) Rapid (TP/HIV) Test Secures the Health Canada’s Approval for Syphilis and HIV

  • December 25, 2024
ViiV Healthcare Reports the CHMP’s Positive Opinion of Vocabria Plus Rekambys for HIV treatment

ViiV Healthcare Reports the CHMP’s Positive Opinion of Vocabria Plus Rekambys for HIV treatment

  • December 18, 2024
ViiV at IDWeek 2024: Dr. Harmony Garges in an Illuminating Dialogue Exchange with PharmaShots

ViiV at IDWeek 2024: Dr. Harmony Garges in an Illuminating Dialogue Exchange with PharmaShots

  • December 16, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.